AVBH vs MRNA · P/E 12, rev $145.8M vs rev $145.0M
Avidbank Holdings Inc (AVBH) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Avidbank Holdings Inc (AVBH) is a banks - regional company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported AVBH revenue for 2025-12-31 was $145.8M. Net income was -$19.6M. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. AVBH currently screens at market cap $164.9M and trailing P/E 12.1.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
AVBH currently screens at market cap $164.9M and trailing P/E 12.1. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the AVBH and MRNA stock pages for the full models.
Not investment advice.